Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 1
2013 3
2015 1
2018 1
2020 2
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kubik a[au] (264 results)?
Impact of cryopreservation on CAR T production and clinical response.
Brezinger-Dayan K, Itzhaki O, Melnichenko J, Kubi A, Zeltzer LA, Jacoby E, Avigdor A, Shapira Frommer R, Besser MJ. Brezinger-Dayan K, et al. Among authors: kubi a. Front Oncol. 2022 Oct 6;12:1024362. doi: 10.3389/fonc.2022.1024362. eCollection 2022. Front Oncol. 2022. PMID: 36276077 Free PMC article.
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response.
Besser MJ, Itzhaki O, Ben-Betzalel G, Zippel DB, Zikich D, Kubi A, Brezinger K, Nissani A, Levi M, Zeltzer LA, Ben-Nun A, Asher N, Shimoni A, Nagler A, Markel G, Shapira-Frommer R, Schachter J. Besser MJ, et al. Among authors: kubi a. Mol Carcinog. 2020 Jul;59(7):736-744. doi: 10.1002/mc.23193. Epub 2020 Apr 6. Mol Carcinog. 2020. PMID: 32250515
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients.
Itzhaki O, Jacoby E, Nissani A, Levi M, Nagler A, Kubi A, Brezinger K, Brayer H, Zeltzer LA, Rozenbaum M, Vernitsky H, Markel G, Toren A, Avigdor A, Schachter J, Besser MJ. Itzhaki O, et al. Among authors: kubi a. J Immunother Cancer. 2020 Mar;8(1):e000148. doi: 10.1136/jitc-2019-000148. J Immunother Cancer. 2020. PMID: 32152221 Free PMC article. Clinical Trial.
Systemic dysregulation of CEACAM1 in melanoma patients.
Markel G, Ortenberg R, Seidman R, Sapoznik S, Koren-Morag N, Besser MJ, Bar J, Shapira R, Kubi A, Nardini G, Tessone A, Treves AJ, Winkler E, Orenstein A, Schachter J. Markel G, et al. Among authors: kubi a. Cancer Immunol Immunother. 2010 Feb;59(2):215-30. doi: 10.1007/s00262-009-0740-5. Cancer Immunol Immunother. 2010. PMID: 19633846
Predicting and controlling the reactivity of immune cell populations against cancer.
Oved K, Eden E, Akerman M, Noy R, Wolchinsky R, Izhaki O, Schallmach E, Kubi A, Zabari N, Schachter J, Alon U, Mandel-Gutfreund Y, Besser MJ, Reiter Y. Oved K, et al. Among authors: kubi a. Mol Syst Biol. 2009;5:265. doi: 10.1038/msb.2009.15. Epub 2009 Apr 28. Mol Syst Biol. 2009. PMID: 19401677 Free PMC article.
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia.
Jacoby E, Bielorai B, Avigdor A, Itzhaki O, Hutt D, Nussboim V, Meir A, Kubi A, Levy M, Zikich D, Zeltzer LA, Brezinger K, Schachter J, Nagler A, Besser MJ, Toren A. Jacoby E, et al. Among authors: kubi a. Am J Hematol. 2018 Dec;93(12):1485-1492. doi: 10.1002/ajh.25274. Epub 2018 Sep 26. Am J Hematol. 2018. PMID: 30187944 Free article. Clinical Trial.
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study.
Greenberg E, Besser MJ, Ben-Ami E, Shapira-Frommer R, Itzhaki O, Zikich D, Levy D, Kubi A, Eyal E, Onn A, Cohen Y, Barshack I, Schachter J, Markel G. Greenberg E, et al. Among authors: kubi a. Biomarkers. 2013 Sep;18(6):502-8. doi: 10.3109/1354750X.2013.816777. Epub 2013 Jul 29. Biomarkers. 2013. PMID: 23902289
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N, Shalmon B, Hardan I, Catane R, Markel G, Apter S, Ben-Nun A, Kuchuk I, Shimoni A, Nagler A, Schachter J. Besser MJ, et al. Among authors: kubi a. Clin Cancer Res. 2010 May 1;16(9):2646-55. doi: 10.1158/1078-0432.CCR-10-0041. Epub 2010 Apr 20. Clin Cancer Res. 2010. PMID: 20406835 Clinical Trial.
13 results